Showing 1 - 10 of 4,589
There are competing views of how HIV/AIDS affects saving, and to a lesser extent, investment. One argument is that …
Persistent link: https://www.econbiz.de/10009647300
and the death rate during birth, the high presence of AIDS, the control of infectious diseases, the emergence of new risks …
Persistent link: https://www.econbiz.de/10005819475
We analyze policy options during an international health emergency to provide consumers in least developed countries access to patented life-extending pharmaceuticals. We show that a properly specified tariff against reexports achieves optimal price dispersion and is shown to depend on the...
Persistent link: https://www.econbiz.de/10004987138
We analyze policy options during an international health emergency to provide consumers in least developed countries access to patented life-extending pharmaceuticals. We show that a properly specified tariff against re?xports achieves optimal price dispersion and is shown to depend on the...
Persistent link: https://www.econbiz.de/10004987147
We analyze policy options during an international health emergency to provide consumers in least developed countries access to patented life-extending pharmaceuticals. Reliance on property rights exhaustion is shown to be insufficiently flexible and costly to implement. By contrast, the optimal...
Persistent link: https://www.econbiz.de/10010594981
Persistent link: https://www.econbiz.de/10008590813
This paper discusses possible strategies for developing countries in negotiations on trade in services in the ongoing WTO Doha Development Round (DR). The liberalization of service imports (including through direct investment) will generate benefits through higher quality, lower prices, and...
Persistent link: https://www.econbiz.de/10005755176
Persistent link: https://www.econbiz.de/10005037308
Persistent link: https://www.econbiz.de/10010993432
Expenditures for HIV-infection are driven mainly by drug costs. We identified several clinical variables influencing the costs of HIV-treatment. This information could assist policymakers when allocating limited health care resources to HIV care. </AbstractSection> Copyright Springer-Verlag 2013
Persistent link: https://www.econbiz.de/10010993926